CNTA: Setting up for a squeezeUsing a blended candle approach, one can see that the sentiment for CNTA is setting up for a squeeze. The volume is contracting over the past few weeks since beginning of the year. Bollinger band is showing signs of a squeeze. ATR (14) is showing lowest volatility over the past 100 day period. The B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.90 EUR
−227.83 M EUR
0.00 EUR
84.29 M
About Centessa Pharmaceuticals plc
Sector
Industry
CEO
Saurabh Saha
Website
Headquarters
Altrincham
Founded
2020
FIGI
BBG0118S87M8
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
$CN'TA is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Centessa Pharmaceuticals is a biopharma holding firm with treatment programs for various diseases.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.